An open label clinical trial to evaluate the efficacy of Vamana Karma in the management of Urdhwaga Amalpitta.â??

Shri Krishna Government Ayurvedic College and Hospital kurukshetra0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•1. Patients having classical sign and symptoms of Urdhwaga Amlapitta as per Ayurvedic
•2. Patient having cardinal symptoms of gastritis and hyperacidity with the duration not more
•than one year.
•3. Male or female between the age group 25- 50 year.
•4. Patients who are fit for Vaman Karma as per ayurvedic classics.

•1. Patients below 25 years and above 50 years.
•2. Patients of Amlapitta with any chronic system disease which interferes with the present
•3. Patients suffering from any current acute illness.
•4. Patients having associated complicated systemic disorders like cardiac diseases, diabetes,
•tuberculosis, bronchial asthma, autoimmune diseases etc.
•5. Known case of gastric and duodenal ulcer.
•6. Known case of gastric carcinoma.
•7. Chronic gastritis (more than one year)
•8. Hiatus hernia, Barrettâ??s esophagus.
•9. Patients with the previous history of hematemesis, hemoptysis or melena.
•10. Patients having congenital physiological anomalies, surgical interventions, and any trauma.
•11. Patients who are contraindicated for Vaman Karma.

发起方

Shri Krishna Government Ayurvedic College and Hospital kurukshetra